{"id":"NCT04048343","sponsor":"AstraZeneca","briefTitle":"Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe Asthma","officialTitle":"A 52-Week, Open-Label, Multicentre Study to Evaluate the Safety of Tezepelumab in Japanese Adults and Adolescents With Inadequately Controlled Severe Asthma (NOZOMI)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-06-10","primaryCompletion":"2021-03-18","completion":"2021-03-18","firstPosted":"2019-08-07","resultsPosted":"2022-06-01","lastUpdate":"2022-06-01"},"enrollment":65,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Severe Asthma"],"interventions":[{"type":"DRUG","name":"Biological: Experimental: Tezepelumab","otherNames":["Tezepelumab"]}],"arms":[{"label":"Tezepelumab","type":"EXPERIMENTAL"}],"summary":"This is an open-label, single arm study designed to evaluate the safety of tezepelumab administered subcutaneously every 4 weeks in Japanese adult and adolescent subjects with inadequately controlled severe asthma.","primaryOutcome":{"measure":"Number of Subjects With Adverse Events","timeFrame":"From first dose of study drug until last study visit at Week 64","effectByArm":[{"arm":"Tezepelumab 210 Q4W","deltaMin":39,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":5,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D5180C00019&amp;attachmentIdentifier=97c43e3b-e498-4f8b-85d5-2faf4536e7c7&amp;fileName=D5180c00019_CSP-v3_Redacted.pdf&amp;versionIdentifier=","https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D5180C00019&amp;attachmentIdentifier=0c96c5d1-f13b-49eb-9068-8e12565da16d&amp;fileName=D5180c00019_CSR_Synopsis_Redacted.pdf&amp;versionIdentifier=","https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D5180C00019&amp;attachmentIdentifier=a5b1e7be-72d8-4ca7-ae06-a71b18e628ec&amp;fileName=D5180c00019_SAP-v3_Redacted.pdf&amp;versionIdentifier="]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":65},"commonTop":["Nasopharyngitis","Pharyngitis","Herpes zoster","Contusion","Back pain"]}}